News

Medicines for Malaria Venture Reflects on Successful Compound Management Partnership with BioAscent

15 July 2024

Medicines for Malaria Venture (MMV), a virtual research organisation which plays a crucial role in malaria control and e...

US biotech uses BioAscent’s compound management service to accelerate screening of 250k library across multiple campaigns

08 July 2024

A US biotech company has partnered with compound management experts BioAscent to build, consolidate and manage its scree...

BioAscent team key part of collaborative European Lead Factory study to identify small molecule inhibitors of a DNA repair nuclease (SNM1A)

26 June 2024

The recently published paper, Cell-active small molecule inhibitors validate the SNM1A DNA repair nuclease as a cancer t...

Highlights in synthesis - unnatural amino acids

24 June 2024

Unnatural amino acids are key building blocks in medicinal chemistry. These motifs are frequently integrated into drug-...

BioAscent obtains cyber essentials plus accreditation

12 June 2024

BioAscent has received Cyber Essentials Plus certification, demonstrating the company’s commitment to cyber security.Cyb...

BioAscent reports year-on-year growth for in silico discovery services

10 June 2024

BioAscent has experienced continued growth in demand for its in silico discovery services. Despite the challenging marke...

Meet the team: Michael Kiczun

30 May 2024

In our latest Meet the Team blog, we hear from Michael Kiczun, Senior Scientist and Team Leader in the medicinal chemist...

Supercharging Reaction Optimisation with 'Pool and Split'

22 May 2024

Welcome to a world where molecules wield extraordinary power, capable of healing, rejuvenating, and transforming lives....

Fundraising for a fantastic cause

14 May 2024

On Saturday 11 May, members of the BioAscent team participated in St Andrew’s Hospice’s annual ‘It’s a Knockout’ fundrai...

Photochemistry illuminates new synthetic routes

24 April 2024

At BioAscent we are thinking differently about making molecules. By encouraging our chemists to disconnect targets in n...

About Us

Integrated Drug Discovery

Compound Management

Publications & Case Studies

News & Events

Careers

Medicines for Malaria Venture Reflects on Successful Compound Management Partnership with BioAscent

US biotech uses BioAscent’s compound management service to accelerate screening of 250k library across multiple campaigns

BioAscent team key part of collaborative European Lead Factory study to identify small molecule inhibitors of a DNA repair nuclease (SNM1A)

Highlights in synthesis - unnatural amino acids

BioAscent obtains cyber essentials plus accreditation

BioAscent reports year-on-year growth for in silico discovery services

Meet the team: Michael Kiczun

Supercharging Reaction Optimisation with 'Pool and Split'

Fundraising for a fantastic cause

Photochemistry illuminates new synthetic routes

Integrated Drug Discovery

Compound Management

Medicinal Chemistry

In Silico Discovery

Discovery Biology

Get in Touch

Our Site

About Us

Integrated Drug Discovery

Compound Management

Publications & Case Studies

News & Events

Careers

News

Medicines for Malaria Venture Reflects on Successful Compound Management Partnership with BioAscent

US biotech uses BioAscent’s compound management service to accelerate screening of 250k library across multiple campaigns

BioAscent team key part of collaborative European Lead Factory study to identify small molecule inhibitors of a DNA repair nuclease (SNM1A)

Highlights in synthesis - unnatural amino acids

BioAscent obtains cyber essentials plus accreditation

BioAscent reports year-on-year growth for in silico discovery services

Meet the team: Michael Kiczun

Supercharging Reaction Optimisation with 'Pool and Split'

Fundraising for a fantastic cause

Photochemistry illuminates new synthetic routes

Integrated Drug Discovery

Compound Management

Medicinal Chemistry

In Silico Discovery

Discovery Biology

Get in Touch